Diabetes mellitus and long-time outcomes of autovenous femoro-popliteal bypass
Open Access
- 15 May 2023
- journal article
- research article
- Published by Endocrinology Research Centre in Diabetes mellitus
- Vol. 26 (2) , 182-191
Abstract
BACKGROUND: the effect of diabetes mellitus on the long-term patency of autovenous femoro-popliteal bypass has not been definitively determined AIM: to determine the effect of diabetes mellitus on the long-term outcomes of autovenous femoral-popliteal bypass.MATERIALS AND METHODS: the results of treatment of 648 patients who underwent autovenous femoral-popliteal bypass were analyzed. The patients were divided into 2 clinical groups: the first group included 367 patients with diabetes mellitus, the second — 281 patients without the named disease. The groups did not differ significantly in the incidence of concomitant pathology.RESULTS: occlusion of the autovenous conduit within a 5-year period after surgical treatment was observed in 218 patients of the first group (59.4%) and 72 patients of the second group (25.6%) (p 2 = 39.05, RR = 1.78; CI = 1.53–2.12). The average service life of the autovenous femoral-popliteal bypass was 63.49 months in patients of the first group, and 107.46 months in the second. The decompensated course of diabetes mellitus was observed in 203 patients (55.2%). Among patients with decompensated diabetes mellitus, occlusion of the autovenous femoral-popliteal bypass was observed in 95 patients (46.8%), in 104 patients the autovenous conduit was passable (51.2%; p = 0.449, χ2 = 0.57). Decompensated course of diabetes mellitus may contribute to a decrease in the service life of autovenous femoro-popliteal bypass.CONCLUSION: the presence of diabetes mellitus, and especially its decompensated course, can negatively affect the patency of autovenous femoro-popliteal bypass in the long term.Keywords
This publication has 19 references indexed in Scilit:
- Arterial hypertension in adults. Clinical guidelines 2020Russian Journal of Cardiology, 2020
- Metabolic disorder and outcomes of reconstructive interventions in patients with peripheral arterial diseaseHERALD of North-Western State Medical University named after I.I. Mechnikov, 2019
- Peripheral Artery Disease: Past, Present, and FutureThe American Journal of Medicine, 2019
- Dyslipidemia Profiles in Patients with Peripheral Artery DiseaseCurrent Cardiology Reports, 2019
- Oxidative Stress and Inflammation: Their Role in the Pathogenesis of Peripheral Artery Disease with or Without Type 2 Diabetes MellitusCurrent Vascular Pharmacology, 2018
- Color Doppler Ultrasonography Is a Useful Tool for Diagnosis of Peripheral Artery Disease in Type 2 Diabetes Mellitus Patients with Ankle-Brachial Index 0.91 to 1.40Diabetes & Metabolism Journal, 2018
- Endothelial deletion of mTORC1 protects against hindlimb ischemia in diabetic mice via activation of autophagy, attenuation of oxidative stress and alleviation of inflammationFree Radical Biology and Medicine, 2017
- Results of various revascularization methods in patients with critical ischemia of lower limbs due to peripheral atherosclerosisRussian Journal of Cardiology and Cardiovascular Surgery, 2017
- Peripheral artery disease: epidemiology and global perspectivesNature Reviews Cardiology, 2016
- The Risk of Disease Progression in Peripheral Arterial Disease is Higher than Expected: A Meta-Analysis of Mortality and Disease Progression in Peripheral Arterial DiseaseEuropean Journal of Vascular and Endovascular Surgery, 2016